Study Design. Retrospective study.
Objective. To evaluate the incidence of fusion failure after anterior screw fixation of type II and rostral shallow type III fractures and to identify related risk factors.
Summary of Background Data. Although several studies have reported fusion rates after anterior odontoid screw fixation of type II and rostral shallow type III fractures, few reports have analyzed in detail the risk factors associated with fusion failure.
Methods. Forty-one patients with a type II and rostral shallow type III odontoid fracture were treated using anterior screw fixation. The patients were 33 men and 8 women mean age = 46.6 years; age range = 15–79 years. Range of follow-up was 7 to 48 months.
Results. Anterior odontoid screw fixation resulted in solid bony union in 33 patients (80.5%), fibrous union in 3 (7.3%), and nonunion in 5 (12.2%). When surgery was delayed for more than 1 week, the incidence of fusion failure significantly increased (P = 0.0051). Furthermore, a fracture gap of 2 mm or more was found to be significantly associated with fusion failure (P = 0.0172). However, patient age and fracture displacement were not found to be significantly associated with fusion failure (P = 0.8236 and P = 0.5762, respectively).
Conclusion. Our study of anterior odontoid screw fixation reveals that the risk of fusion failure is 37.5 times greater in patients with a delay of more than 1 week before operation, and 21 times greater in patients with a fracture gap of greater than 2 mm.
We analyzed the risk factors associated with fusion failure after anterior odontoid screw fixation. Fusion failure was 37.5 times more likely if surgery was delayed by over 1 week, and 21 times more probable if the fracture gap was 2 mm or more.
From the Department of Neurosurgery, Kyungpook National University Hospital, Daegu, Republic of Korea.
Address correspondence and reprint requests to Joo-Kyung Sung, MD, PhD, Department of Neurosurgery, Kyungpook National University Hospital, 50 Samduk-2-ga, Jung-gu, Daegu 700–721, Republic of Korea; E-mail: email@example.com
Acknowledgment date: May 5, 2010. First revision date: September 24, 2010. Second revision date: November 10, 2010. Third revision date: December 21, 2010. Acceptance date: December 22, 2010.
The manuscript submitted does not contain information about medical device(s)/drug(s).
Institutional funds were received to support this work. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.